×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
DHR – danaher corporation (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
DHR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/17
03:02 am
dhr
Danaher Co. (NYSE: DHR) was given a new $231.00 price target on by analysts at Robert W. Baird.
Low
Report
Danaher Co. (NYSE: DHR) was given a new $231.00 price target on by analysts at Robert W. Baird.
4/16
01:14 pm
dhr
Global In-Vitro Diagnostics Market Predicted to Surpass the USD 90 Billion Mark by 2032 | DelveInsight [Yahoo! Finance]
Low
Report
Global In-Vitro Diagnostics Market Predicted to Surpass the USD 90 Billion Mark by 2032 | DelveInsight [Yahoo! Finance]
4/13
05:58 pm
dhr
Is Danaher Corporation (DHR) the Best Medical Stock to Buy According to Billionaires? [Yahoo! Finance]
Low
Report
Is Danaher Corporation (DHR) the Best Medical Stock to Buy According to Billionaires? [Yahoo! Finance]
4/10
01:41 pm
dhr
Oxford Nanopore inks infectious disease analysis pact with Cepheid [Yahoo! Finance]
Low
Report
Oxford Nanopore inks infectious disease analysis pact with Cepheid [Yahoo! Finance]
4/9
07:38 am
dhr
Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-Based Solutions [Yahoo! Finance]
High
Report
Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-Based Solutions [Yahoo! Finance]
4/7
08:44 am
dhr
ALZpath Named 2025 BRONZE Edison Award Winner for its Proprietary pTau217 Antibody, a Key Biomarker Driving Blood-Based Alzheimer's Disease Diagnostics [Yahoo! Finance]
Low
Report
ALZpath Named 2025 BRONZE Edison Award Winner for its Proprietary pTau217 Antibody, a Key Biomarker Driving Blood-Based Alzheimer's Disease Diagnostics [Yahoo! Finance]
4/7
08:13 am
dhr
Danaher Co. (NYSE: DHR) had its "buy" rating re-affirmed by analysts at Citigroup Inc..
Low
Report
Danaher Co. (NYSE: DHR) had its "buy" rating re-affirmed by analysts at Citigroup Inc..
4/3
09:32 am
dhr
Anatomic Pathology Market to Reach USD 74.64 Billion by 2032, Driven by Rising Cancer Prevalence and Technological Advancements in Diagnostics | SNS Insider [Yahoo! Finance]
Low
Report
Anatomic Pathology Market to Reach USD 74.64 Billion by 2032, Driven by Rising Cancer Prevalence and Technological Advancements in Diagnostics | SNS Insider [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/26
08:18 am
dhr
Form ARS DANAHER CORP /DE/ For: Dec 31
Low
Report
Form ARS DANAHER CORP /DE/ For: Dec 31
3/26
08:06 am
dhr
Form DEF 14A DANAHER CORP /DE/ For: May 06
Low
Report
Form DEF 14A DANAHER CORP /DE/ For: May 06
3/11
04:04 pm
dhr
Form 144 DANAHER CORP /DE/ Filed by: King William
Low
Report
Form 144 DANAHER CORP /DE/ Filed by: King William
3/5
05:00 pm
dhr
Form 4 DANAHER CORP /DE/ For: Feb 01 Filed by: GRAY R BRADLEY
Low
Report
Form 4 DANAHER CORP /DE/ For: Feb 01 Filed by: GRAY R BRADLEY
3/4
07:01 pm
dhr
Form 4 DANAHER CORP /DE/ For: Mar 01 Filed by: Lamanna Charles W
Low
Report
Form 4 DANAHER CORP /DE/ For: Mar 01 Filed by: Lamanna Charles W
3/4
05:02 pm
dhr
Form 4 DANAHER CORP /DE/ For: Mar 01 Filed by: Riley Christopher Paul
Low
Report
Form 4 DANAHER CORP /DE/ For: Mar 01 Filed by: Riley Christopher Paul
3/4
05:02 pm
dhr
Form 4 DANAHER CORP /DE/ For: Mar 01 Filed by: Couchara Georgeann
Low
Report
Form 4 DANAHER CORP /DE/ For: Mar 01 Filed by: Couchara Georgeann
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/12
Form 4/A DANAHER CORP /DE/ For: Feb 20 Filed by: Blair Rainer
9.7%
4/6 Form 424B5 DANAHER CORP /DE/ 7.7%
3/23 Form 4 DANAHER CORP /DE/ For: Mar 20 Filed by: SPOON ALAN G 6.2%
4/2 Danaher Co. (NYSE: DHR) was downgraded by analysts at Wolfe Research from an "outperform" rating to a "market perform" rating. 5.7%
1/30 Form 8-K DANAHER CORP /DE/ For: Jan 30 5.7%
3/26 Danaher Co. (NYSE: DHR) was upgraded by analysts at Royal Bank of Canada to a "buy" rating. They now have a $157.00 price target on the stock. 5.2%
4/3 Danaher Prices Reopening Of Euro-Denominated Senior Notes 5.0%
11/15 Form 425 DANAHER CORP /DE/ Filed by: DANAHER CORP /DE/ 5.0%
4/13 Rapid portable COVID-19 tests on the way to remote communities [Toronto Globe and Mail (Ontario, Canada)] 4.1%
4/22 Beckman Coulter announces May launch of its SARS-CoV-2 serology test and ramps production to deliver over 30 million tests per month 4.0%
4/6 Form 424B5 DANAHER CORP /DE/ 7.7%
3/23 Form 4 DANAHER CORP /DE/ For: Mar 20 Filed by: SPOON ALAN G 6.2%
4/2 Danaher Co. (NYSE: DHR) was downgraded by analysts at Wolfe Research from an "outperform" rating to a "market perform" rating. 5.7%
1/30 Form 8-K DANAHER CORP /DE/ For: Jan 30 5.7%
3/26 Danaher Co. (NYSE: DHR) was upgraded by analysts at Royal Bank of Canada to a "buy" rating. They now have a $157.00 price target on the stock. 5.2%
4/3 Danaher Prices Reopening Of Euro-Denominated Senior Notes 5.0%
11/15 Form 425 DANAHER CORP /DE/ Filed by: DANAHER CORP /DE/ 5.0%
4/13 Rapid portable COVID-19 tests on the way to remote communities [Toronto Globe and Mail (Ontario, Canada)] 4.1%
4/22 Beckman Coulter announces May launch of its SARS-CoV-2 serology test and ramps production to deliver over 30 million tests per month 4.0%
TOP News Decliners
3/23
How to Prevent a Coronavirus Depression [The New York Times]
-9.7%
3/31 Danaher Completes Acquisition Of The Biopharma Business Of General Electric Life Sciences; Business Will Be Called Cytiva -6.7%
3/16 IDT Achieves Large-Scale Manufacturing Success of Key COVID-19 Test Component -5.7%
1/30 Danaher Co. (NYSE: DHR) had its price target raised by analysts at Piper Sandler from to . -4.8%
3/6 Form 4 DANAHER CORP /DE/ For: Mar 04 Filed by: DANIEL WILLIAM K -4.6%
3/25 Form 424B5 DANAHER CORP /DE/ -3.5%
9/9 GE's Culp Is On Track To Slash Debt By Up To $38 Billion, Possibly In Q3 '19 [Seeking Alpha] -3.4%
9/9 Danaher To Webcast Water Quality Platform Investor And Analyst Meeting At Hach -3.1%
4/27 Form 4 DANAHER CORP /DE/ For: Apr 24 Filed by: HEFNER LINDA P -3.1%
2/24 Form 4 DANAHER CORP /DE/ For: Feb 20 Filed by: King William -2.9%
3/31 Danaher Completes Acquisition Of The Biopharma Business Of General Electric Life Sciences; Business Will Be Called Cytiva -6.7%
3/16 IDT Achieves Large-Scale Manufacturing Success of Key COVID-19 Test Component -5.7%
1/30 Danaher Co. (NYSE: DHR) had its price target raised by analysts at Piper Sandler from to . -4.8%
3/6 Form 4 DANAHER CORP /DE/ For: Mar 04 Filed by: DANIEL WILLIAM K -4.6%
3/25 Form 424B5 DANAHER CORP /DE/ -3.5%
9/9 GE's Culp Is On Track To Slash Debt By Up To $38 Billion, Possibly In Q3 '19 [Seeking Alpha] -3.4%
9/9 Danaher To Webcast Water Quality Platform Investor And Analyst Meeting At Hach -3.1%
4/27 Form 4 DANAHER CORP /DE/ For: Apr 24 Filed by: HEFNER LINDA P -3.1%
2/24 Form 4 DANAHER CORP /DE/ For: Feb 20 Filed by: King William -2.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: